| abstract |
The present invention provides compounds of the formula (I):-n and the pharmaceutically acceptable salts thereof, wherein n R is C 3 -C 7 cycloalkyl, aryl or C 1 -C 6 alkyl, said C 1 -C 6 alkyl being optionally substituted by fluoro, -COOH, -COO(C 1 -C 4 ) alkyl, C 3 -C 7 cycloalkyl, adamantyl, aryl or het 1 , and said C 3 -C 7 cycloalkyl being optionally substituted by 1 or 2 substituents each independently selected from C 1 -C 4 alkyl, C 3 -C 7 cycloalkyl, C 1 -C 4 alkoxy, hydroxy, fluoro, fluoro(C 1 -C 4 ) alkyl and fluoro(C 1 -C 4 )alkoxy;n R 1 is phenyl, benzyl, naphthyl, thienyl, benzothienyl or indolyl, each optionally substituted by 1 or 2 substituents each independently selected from C 1 -C 4 alkyl, C 1 -C 4 alkoxy, halo and trifluoromethyl; R 2 represents various groups; X is C 1 -C 4 alkylene; and X 1 is a direct link or C 1 -C 6 alkylene. n Such compounds and salts are useful as tachykinin antagonists. |